BRAF NP_004324.2:p.V600E

我们是谁

  • 4 月 5, 2022
    Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer